ASX:4DXHealthcare Services
Can 4DMedical's (ASX:4DX) Rising Revenue Offset Its Deepening Net Losses?
In the past financial year ended June 30, 2026, 4DMedical Limited reported A$7.06 million in sales, up from A$5.85 million, alongside a net loss of A$204.44 million compared with A$30.07 million previously.
Despite the wider net loss, the company’s basic and diluted loss per share from continuing operations improved to A$0.03 from A$0.14, highlighting the effect of a larger share base on per-share metrics.
We will now examine how 4DMedical’s combination of higher revenue and a very large...